Spain, March 18 -- Spain based INSTITUTO GRIFOLS, S.A. has secured contract from Direccion del Instituto Nacional de Gestion Sanitaria (INGESA) for Extracts Plasma - Supply of Hemoderivated Products for Therapeutic Use from the Industrial Fractionation of Human Plasma from the National Health System. The value of the contract is worth 15294 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....